
Patients taking some newer diabetes medications – SGLT2 inhibitors – have been warned that they may be at risk of …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

